BMC Cancer 2008, 8:30 http://www.biomedcentral.com/1471-2407/8/30 References 1. Kushner BH, Kramer K, LaQuaglia MP, Modak S, Cheung NK: Neu- roblastoma in adolescents and adults: the Memorial Sloan- Kettering experience. Med Pediatr Oncol 2003, 41:508-515. 2. Ross RA, Biedler JL, Spengler BA: A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett 2003, 197:35-39. 3. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, Cheung NK, Ross RA: Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6:838-845. 4. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, Biedler JL: Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 1995, 6:449-456. 5. Castel V, Canete A: A comparison of current neuroblastoma chemotherapeutics. Expert Opin Pharmaco 2004, 5:71-80. 6. Oltra S, Martinez F, Orellana C, Grau E, Fernandez JM, Canete A, Castel V: The Doublecortin Gene, A New Molecular Marker to Detect Minimal Residual Disease in Neuroblastoma. Diagn Mol Pathol 2005, 14:53-57. 7. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M: Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005, 65:4051-4058. 8. Bernreuther C, Salein N, Matschke J, Hagel C: Expression of dou- blecortin in tumours of the central and peripheral nervous system and in human non-neuronal tissues. Acta Neuropathol (Berl) 2006, 111:247-254. 9. Daou MC, Smith TW, Litofsky NS, Hsieh CC, Ross AH: Doublecor- tin is preferentially expressed in invasive human brain tumors. Acta Neuropathol (Berl) 2005, 110:472-480. 10. des Portes V, Pinard JM, Billuart P, Vinet MC, Koulakoff A, Carrie A, Gelot A, Dupuis E, Motte J, Berwald-Netter Y, Catala M, Kahn A, Beldjord C, Chelly J: A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar het- erotopia and lissencephaly syndrome. Cell 1998, 92:51-61. 11. des Portes V, Francis F, Pinard JM, Desguerre I, Moutard ML, Snoeck I, Meiners LC, Capron F, Cusmai R, Ricci S, Motte J, Echenne B, Pon- sot G, Dulac O, Chelly J, Beldjord C: Doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet 1998, 7:1063-1070. 12. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA: Dou- blecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a puta- tive signaling protein. Cell 1998, 92:63-72. 13. Gleeson JG, Lin PT, Flanagan LA, Walsh CA: Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999, 23:257-271. 14. Tanaka T, F. Serneo FF, Tseng H, Kulkarni AB, Tsai L, Gleeson JG: Cdk5 Phosphorylation of Doublecortin Ser297 Regulates Its Effect on Neuronal Migration. Neuron 2004, 41:215-227. 15. Lo Turco J: Doublecortin and a tale of two serines. Neuron 2004, 41:175-177. 16. Caspi M, Atlas R, Kantor A, Sapir T, Reiner O: Interaction between LIS1 and doublecortin, two lissencephaly gene products. Hum Mol Genet 2000, 9:2205-2213. 17. Tanaka T, Serneo FF, Higgins C, Gambello MJ, Wynshaw-Boris A, Gleeson JG: Lis1 and doublecortin function with dynein to mediate coupling of the nucleus to the centrosome in neuro- nal migration. J Cell Biol 2004, 165:709-721. 18. Heraud C, Hilairet S, Muller JM, Leterrier JF, Chadeneau C: Neuri- togenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histi- dine methionine in SH-SY5Y cells is associated with regu- lated expression of cytoskeleton mRNAs and proteins. J Neurosci Res 2004, 75:320-329. 19. Yarrow JC, Perlman ZE, Westwood NJ, Mitchison TJ: A high- throughput cell migration assay using scratch wound heal- ing, a comparison of image-based readout methods. BMC Bio- technology 2004, 4:21-30. 20. Mehta K, Fok J, Miller FR, Koul D, Sahin AA: Prognostic signifi- cance of tissue transglutaminase in drug resistant and meta- static breast cancer. Clin Cancer Res 2004, 10:8068-8076. 21. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 22. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, Reynolds CP: Phase I trial of 13-cis-retinoic acid in chil- dren with neuroblastoma following bone marrow transplan- tation. J Clin Oncol 1995, 13:894-901. 23. Ratka A, Flores BM, Mambourg SE, Torian BE: Luteinizing hor- mone-releasing hormone in undifferentiated and differenti- ated SK-N-SH human neuroblastoma cells. Neuropeptides 1996, 30:87-94. 24. Voigt A, Zintl F: Effects of retinoic acid on proliferation, apop- tosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol 2003, 40:205-213. 25. Shmueli A, Gdalyahu A, Sapoznik S, Sapir T, Tsukada M, Reiner O: Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1). Mol Cell Neurosci 2006, 32:15-26. 26. Corbo JC, Deuel TA, Long JM, LaPorte P, Tsai E, Wynshaw-Boris A, Walsh CA: Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J Neurosci 2002, 22:7548-7557. 27. Bai J, Ramos RL, Ackman JB, Thomas AM, Lee RW, LoTurco JJ: RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci 2003, 6:1277-1283. 28. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC, Fri- ocourt G, McDonnell N, Reiner O, Kahn A, McConnell SK, Berwald- Netter Y, Denoulet P, Chelly J: Doublecortin is a developmen- tally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 1999, 23:247-256. 29. Friocourt G, Koulakoff A, Chafey P, Boucher D, Fauchereau F, Chelly J, Francis F: Doublecortin functions at the extremities of grow- ing neuronal processes. Cereb Cortex 2003, 13:620-626. 30. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C, Comella JX: Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000, 75:991-1003. 31. Wainwright LJ, Lasorella A, Iavarone A: Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci U S A 2001, 98:9396-93400. 32. Joshi S, Guleria R, Pan J, Dipette D, Singh US: Retinoic acid recep- tors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells. Oncogene 2006, 25:240-247. 33. Dubey M, Hoda S, Chan WK, Pimenta A, Ortiz DD, Shea TB: Reex- pression of vimentin in differentiated neuroblastoma cells enhances elongation of axonal neurites. J Neurosci Res 2004, 78:245-249. 34. Kempermann G, Jessberger S, Steiner B, Kronenberg G: Milestones of neuronal development in the adult hippocampus. Trends Neurosci 2004, 27:447-452. 35. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T: Opinion: migrating cancer stem cells - an integrated concept of malig- nant tumour progression. Nat Rev Cancer 2005, 5:744-749. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/8/30/prepub Page 12 of 12 (page number not for citation purposes)